Apellis Pharmaceuticals (APLS) Stock Research

APLS

· APLS

Over a week ago

Kailera Therapeutics appoints Nur Nicholson as chief technology officer

Aug 11, 7:35 AM

Two new option listings and fifteen option delistings on June 23rd

+10

Jun 23, 8:30 AM

Biogen completes acquisition of Apellis Pharmaceuticals

May 14, 8:50 AM

Remitly Global to replace Apellis in S&P 600 at open on 5/14

May 7, 5:26 PM

Biogen price target raised by $14 at Guggenheim, here's why

Apr 30, 6:49 AM

Biogen reports Q1 adjusted EPS $3.57, consensus $2.95

Apr 29, 6:08 AM

Wells Fargo downgrades Apellis to Equal Weight following Biogen's acquisition

Apr 17, 6:29 AM

Wells Fargo gets more bearish on Apellis, downgrades shares

APLS

Apr 17, 5:18 AM

Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls

+25

Apr 14, 9:53 AM

Apellis price target raised by $20 at RBC Capital, here's why

APLS

Apr 7, 9:39 AM

Apellis price target raised by $21 at Mizuho, here's why

APLS

Apr 2, 6:54 AM

Apellis just downgraded at Roth Capital, here's why

APLS

Apr 2, 4:25 AM

Disney upgraded, Nike downgraded: Wall Street's top analyst calls

+29

Apr 1, 9:46 AM

Biogen price target raised by $25 at Oppenheimer, here's why

Apr 1, 8:02 AM

Apellis just downgraded at H.C. Wainwright, here's why

APLS

Apr 1, 6:06 AM

Apellis just downgraded at Raymond James, here's why

APLS

Apr 1, 5:39 AM

Apellis just downgraded at JPMorgan, here's why

APLS

Apr 1, 5:35 AM

Apellis just downgraded at Cantor Fitzgerald, here's why

APLS

Mar 31, 6:20 PM

Apellis just downgraded at Stifel, here's why

APLS

Mar 31, 4:29 PM

What You Missed On Wall Street On Tuesday

+26

Mar 31, 4:25 PM

Apellis just downgraded at Citi, here's why

Mar 31, 4:10 PM

Apellis just downgraded at Jefferies, here's why

Mar 31, 1:13 PM

Chardan sees positive read-through to Annexon's vonaprument from Apellis deal

Mar 31, 1:07 PM

Apellis price target raised by $16 at Morgan Stanley, here's why

Mar 31, 12:48 PM

Charts

Over a week ago

Kailera Therapeutics appoints Nur Nicholson as chief technology officer

Aug 11, 7:35 AM

Two new option listings and fifteen option delistings on June 23rd

+10

Jun 23, 8:30 AM

Biogen completes acquisition of Apellis Pharmaceuticals

May 14, 8:50 AM

Remitly Global to replace Apellis in S&P 600 at open on 5/14

May 7, 5:26 PM

Biogen price target raised by $14 at Guggenheim, here's why

Apr 30, 6:49 AM

Biogen reports Q1 adjusted EPS $3.57, consensus $2.95

Apr 29, 6:08 AM

Wells Fargo downgrades Apellis to Equal Weight following Biogen's acquisition

Apr 17, 6:29 AM

Wells Fargo gets more bearish on Apellis, downgrades shares

APLS

Apr 17, 5:18 AM

Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls

+25

Apr 14, 9:53 AM

Apellis price target raised by $20 at RBC Capital, here's why

APLS

Apr 7, 9:39 AM

Apellis price target raised by $21 at Mizuho, here's why

APLS

Apr 2, 6:54 AM

Apellis just downgraded at Roth Capital, here's why

APLS

Apr 2, 4:25 AM

Disney upgraded, Nike downgraded: Wall Street's top analyst calls

+29

Apr 1, 9:46 AM

Biogen price target raised by $25 at Oppenheimer, here's why

Apr 1, 8:02 AM

Apellis just downgraded at H.C. Wainwright, here's why

APLS

Apr 1, 6:06 AM

Apellis just downgraded at Raymond James, here's why

APLS

Apr 1, 5:39 AM

Apellis just downgraded at JPMorgan, here's why

APLS

Apr 1, 5:35 AM

Apellis just downgraded at Cantor Fitzgerald, here's why

APLS

Mar 31, 6:20 PM

Apellis just downgraded at Stifel, here's why

APLS

Mar 31, 4:29 PM

What You Missed On Wall Street On Tuesday

+26

Mar 31, 4:25 PM

Apellis just downgraded at Citi, here's why

Mar 31, 4:10 PM

Apellis just downgraded at Jefferies, here's why

Mar 31, 1:13 PM

Chardan sees positive read-through to Annexon's vonaprument from Apellis deal

Mar 31, 1:07 PM

Apellis price target raised by $16 at Morgan Stanley, here's why

Mar 31, 12:48 PM

Company News

Charts

APLS

· APLS

Company News

Charts

APLS

· APLS